10074-G5

CAS No. 413611-93-5

10074-G5( 10074G5 )

Catalog No. M14417 CAS No. 413611-93-5

A small molecules that disrupts c-Myc-Max heterodimerization.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 60 In Stock
2MG 33 In Stock
5MG 54 In Stock
10MG 76 In Stock
25MG 138 In Stock
50MG 220 In Stock
100MG 388 In Stock
200MG 553 In Stock
500MG 882 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    10074-G5
  • Note
    Research use only, not for human use.
  • Brief Description
    A small molecules that disrupts c-Myc-Max heterodimerization.
  • Description
    A small molecules that disrupts c-Myc-Max heterodimerization; binds to and distorts the bHLH-ZIP domain of c-Myc; inhibits the growth of Daudi Burkitt's lymphoma cells and disrupts c-Myc/Max dimerization.
  • In Vitro
    10074-G5 inhibits the growth of Daudi Burkitt's lymphoma cells and disruptes c-Myc/Max dimerization. The IC50 values against Daudi and HL-60 cells are 15.6 and 13.5 μM, respectively. 10074-G5 binds the Myc peptide Myc353-437 with a Kd value of 2.8 μM in the region Arg363-Ile381. 10074-G5 binds in a cavity that is created by a kink (Asp379-Ile381) in the N-terminus of an induced helical domain (Leu370–Arg378).
  • In Vivo
    The plasma half-life of 10074-G5 in mice treated with 20 mg/kg i.v. is 37 min, and peak plasma concentration was 58 μM, which is 10-fold higher than peak tumor concentration.
  • Synonyms
    10074G5
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    c-Myc
  • Recptor
    c-Myc
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    413611-93-5
  • Formula Weight
    332.31288
  • Molecular Formula
    C18H12N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 28 mg/mL
  • SMILES
    O=[N+](C1=CC=C(NC2=CC=CC=C2C3=CC=CC=C3)C4=CNON41)[O-]
  • Chemical Name
    2,1,3-Benzoxadiazol-4-amine, N-[1,1'-biphenyl]-2-yl-7-nitro-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Follis AV, et al. Chem Biol. 2008 Nov 24;15(11):1149-55. 2. Clausen DM, et al. J Pharmacol Exp Ther. 2010 Dec;335(3):715-27. 3. Hammoudeh DI, et al. J Am Chem Soc. 2009 Jun 3;131(21):7390-401.
molnova catalog
related products
  • IRES-J007

    An improved IRES inhibitor that blocks IRES-hnRNP A1 binding.

  • Stauprimide

    A staurosporine analog that promotes embryonic stem cell (ESC) differentiation by inhibiting nuclear localization of the MYC transcription factor NME2.

  • APTO-253

    APTO-253 inhibits c-Myc expression, stabilizes G-quadruplex DNA, and induces cell cycle arrest and apoptosis in acute myeloid leukemia cells. APTO-253 mediates anticancer activity through the induction of the KLF4 tumor suppressor.APTO-253 (5 μM) induces KLF4 expression and enhances apoptosis induced by NSC 119875 in both SKOV3 and OVCAR3 cells.